Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

China flag China · Delayed Price · Currency is CNY
3.350
+0.050 (1.52%)
Apr 30, 2026, 11:54 AM CST
-1.76%
Market Cap 6.26B
Revenue (ttm) 5.62B
Net Income (ttm) 120.29M
Shares Out 1.90B
EPS (ttm) 0.06
PE Ratio 52.05
Forward PE n/a
Dividend 0.06 (1.89%)
Ex-Dividend Date n/a
Volume 29,109,492
Average Volume 31,436,783
Open 3.150
Previous Close 3.300
Day's Range 3.150 - 3.370
52-Week Range 2.960 - 4.150
Beta 0.30
RSI 58.53
Earnings Date Apr 21, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological medications, and anti-infective drugs. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China. [Read more]

Sector Healthcare
Founded 1995
Employees 5,059
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2025, SHE:002390's revenue was 5.62 billion, a decrease of -6.84% compared to the previous year's 6.03 billion. Earnings were 120.29 million, an increase of 18.65%.

Financial Statements

News

There is no news available yet.